欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0533/003
药品名称Bosutinib TEVA
活性成分
    • Bosutinib dihydrate 500.0 mg
剂型Film-coated tablet
上市许可持有人Teva GmbH Graf-Arco-Str. 3 89079 Ulm Germany Germany
参考成员国 - 产品名称Iceland (IS)
Bosutinib TEVA
互认成员国 - 产品名称
    • Denmark (DK)
      Bosutinib "Teva"
    • Romania (RO)
    • Belgium (BE)
      Bosutinib Teva 500 mg filmomhulde tabletten
    • Croatia (HR)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Bulgaria (BG)
      Bosutinib TEVA
    • Germany (DE)
      Bosutinib-ratiopharm 500 mg Filmtabletten
    • Czechia (CZ)
      Bosutinib Teva
许可日期2024/08/12
最近更新日期2025/01/10
药物ATC编码
    • L01EA04 bosutinib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase